Skip to content
Blood-Based Mutation Testing: Circulating Tumor Cells and Tumor DNA episode artwork

Jan 19, 2016 2 min

Blood-Based Mutation Testing: Circulating Tumor Cells and Tumor DNA

from GRACEcast Hosted by cancerGRACE Meetings

Dr. Ed Kim from the Levine Cancer Institute reviews the potential advantages and current limitations of blood-based testing for molecular markers using circulating tumor cells and circulating tumor DNA in identifying clinically important mutations.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Blood-Based Mutation Testing: Circulating Tumor Cells and Tumor DNA

0:00 2:49

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of GRACEcast?

This episode is 2 minutes long.

When was this GRACEcast episode published?

This episode was published on January 19, 2016.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.